Clinical trial
A Multicenter, Randomized, Double-Blind, Controlled Trial Comparing Local Infiltration Analgesia With EXPAREL to Local Infiltration Analgesia Without EXPAREL to Manage Postsurgical Pain Following Total Knee Arthroplasty
NCT02713490 is registered in ClinicalTrials.gov with Pacira Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Controlled Trial Comparing Local Infiltration Analgesia With EXPAREL to Local Infiltration Analgesia Without EXPAREL to Manage Postsurgical Pain Following Total Knee Arthroplasty
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 18, 2016
- Completion date
- February 8, 2017
- Enrollment
- 140 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.